Enact (ACT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Delivered GAAP net income of $163 million ($1.10 per diluted share) and adjusted operating income of $166 million ($1.12 per diluted share) for Q3 2025, reflecting a sequential and year-over-year decline.
Insurance in-force reached $272 billion, supported by $14 billion in new insurance written and an 83% persistency rate, with strong capital and liquidity positions maintained.
Raised full-year 2025 capital return guidance to approximately $500 million, the highest since IPO, reflecting business strength and higher mortgage originations.
Declared a $0.21 per share quarterly dividend and repurchased 2.8 million shares for $105 million in Q3, with further buybacks post-quarter.
Entered a new $435 million revolving credit facility, replacing a $200 million facility, enhancing financial flexibility.
Financial highlights
Net income for Q3 2025 was $163 million, down from $168 million in Q2 2025 and $181 million in Q3 2024; adjusted operating income was $166 million, down from $174 million in Q2 2025 and $182 million in Q3 2024.
Net premiums earned were $245 million, flat sequentially and down year-over-year due to higher ceded premiums.
Net investment income reached $69 million, up 4% sequentially and 12% year-over-year.
Loss ratio increased to 15% from 10% in Q2 2025 and 5% in Q3 2024, reflecting higher losses incurred.
Book value per share excluding AOCI reached $36.82, continuing a trend of accretion since IPO.
Outlook and guidance
Full-year 2025 capital return guidance increased to approximately $500 million, subject to business performance, market conditions, and regulatory approvals.
2025 expense forecast, excluding reorganization costs, lowered to ~$219 million from prior $220–$225 million range.
Management expects to maintain capital sufficiency well above regulatory requirements despite upcoming changes to PMIERS asset standards.
Confident in ability to deliver through economic cycles, supported by strong balance sheet and prudent risk management.
Final capital return amount and form will depend on business performance, market conditions, and regulatory approvals.
Latest events from Enact
- Q4 2025 net income rose to $177.2M, ROE reached 13.5%, and a $500M buyback was announced.ACT
Q4 20254 Feb 2026 - Record insurance in-force, strong earnings, and 2024 capital return guidance raised to $350M.ACT
Q2 20242 Feb 2026 - Strong returns, resilient business model, and demographic tailwinds drive future growth.ACT
TD Financial Services & Fintech Summit1 Feb 2026 - Q3 net income reached $181M, with record insurance in-force and strong capital returns.ACT
Q3 202416 Jan 2026 - Q1 2025 net income rose to $166M, with robust capital returns and a higher dividend.ACT
Q1 202524 Dec 2025 - Record earnings, strong capital, and $354M capital return highlight robust 2024 performance.ACT
Q4 202417 Dec 2025 - Record net income, strong capital, and robust governance highlight 2025 proxy proposals.ACT
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify KPMG as auditor for 2025.ACT
Proxy Filing1 Dec 2025 - Q2 2025 saw $168M net income, $116M capital returned, and robust capital strength maintained.ACT
Q2 20253 Nov 2025